MagDI™ System
Side-to-side duodeno-ileal anastomosis for weight loss and glycemic control in severe obesity with/without type 2 diabetes
ApprovedActive
Key Facts
Indication
Side-to-side duodeno-ileal anastomosis for weight loss and glycemic control in severe obesity with/without type 2 diabetes
Phase
Approved
Status
Active
Company
About GT Metabolic Solutions
GT Metabolic Solutions is a private medical device innovator at the forefront of magnetic surgery. The company has achieved significant regulatory milestones, including FDA De Novo authorization and 510(k) clearances for its MagDI™ System, which creates a side-to-side duodeno-ileal (DI) anastomosis. Its incisionless magnetic anastomosis platform aims to reinvent bariatric, metabolic, and digestive surgery by eliminating staples and sutures, potentially improving patient outcomes and recovery. The company is in the early commercial stage, partnering with surgeons globally to launch its technology in the U.S. market.
View full company profile